In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and –Resistant melanoma cells
Open accessThe DOI matches its Crossref record.
Abstract
We studied effects of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], its analog seocalcitol (EB 1089), and 25-hydroxyvitamin D3 [25(OH)D3], on the growth of seven melanoma cell lines. While three cell lines (MeWo, SK-Mel-28, SM) responded to antiproliferative effects of active vitamin D analogs, the others (SK-Mel-5, SK-Mel-25, IGR, MeUuso) were resistant. A strong induction (7000-fold) of 1,25-dihydroxyvitamin D-24-hydroxylase (24OHase, CYP24) mRNA was detected in responsive cell lines along with 1,25(OH)2D3-treatment, indicating functional integrity of vitamin D receptor (VDR)-mediated transcription. In contrast, induction of 24OHase was much lower in resistant melanoma cells (70-fold). VDR mRNA was induced up to 3-fold both in responsive and resistant cell lines along with 1,25(OH)2D3-treatment. RNA for vitamin D-activating enzymes vitamin D-25-hydroxylase (25OHase, CYP27A1) and 25-hydroxyvitamin D-lalpha-hydroxylase (lalphaOHase, CYP27B1) was detected in all melanoma cell lines analyzed, additionally we show splicing variants of lalphaOHase in SK-Mel-28 cells. Expression of 250Hase and laOHase was marginally modulated along with treatment. Proliferation of melanoma cells was not inhibited by treatment with 25(OH)D3, indicating no significant stimulation of endogeneous production of antiproliferative acting 1,25(OH)2D3. In conclusion, we characterize the vitamin D endocrine system in melanoma cells and demonstrate that the majority of melanoma cell lines analyzed is resistant to antiproliferative effects of 1,25(OH)2D3. It can be speculated that these alterations are of importance for pathogenesis and growth of metastasizing malignant melanoma. Additionally, our findings indicate that only a minority of cases with metastasizing melanoma may represent a promising target for palliative treatment with new vitamin D analogs that exert little calcemic side effects or for pharmacological modulation of 1,25(OH)2D3-synthesis/metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Khundmiri, S. J., Murray, R. D., & Lederer, E. (2016) · Comprehensive Physiology · doi:10.1002/cphy.c140071 · Cited by 296
Slominski, A. T., Brożyna, A. A., Zmijewski, M. A., Jóźwicki, W., Jetten, A. M., Mason, R. S., Tuckey, R. C., & Elmets, C. A. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.3 · Cited by 136
Expression of vitamin D receptor decreases during progression of pigmented skin lesions
Brożyna, A. A., Jozwicki, W., Janjetovic, Z., & Slominski, A. T. (2011) · Human Pathology · doi:10.1016/j.humpath.2010.09.014 · Cited by 120
“These results are in agreement with cell culture–based studies that suggested a role for VDR in biology of melanomas [21,22] as well as with populationbased studies showing that VDR gene polymorphism [27,30,32,33] or local generation of vitamin D or levels of circulating 25(OH)D3 [6,25,28,29] can alter disease suscept…”
A Cohort Study of Vitamin D Intake and Melanoma Risk
Asgari, M. M., Maruti, S. S., Kushi, L. H., & White, E. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.451 · Cited by 85
“The antiproliferative and prodifferentiation effects of vitamin D and its metabolites have been demonstrated in some melanoma cell lines in vitro (Colston et al., 1981; Evans et al., 1996; Seifert et al., 2004; Reichrath et al., 2007).”
Fang, S., Sui, D., Wang, Y., Liu, H., Chiang, Y.-J., Ross, M. I., Gershenwald, J. E., Cormier, J. N., Royal, R. E., Lucci, A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.1357 · Cited by 71
Brożyna, A. A., Jóźwicki, W., Janjetovic, Z., & Slominski, A. T. (2013) · Human Pathology · doi:10.1016/j.humpath.2012.03.031 · Cited by 70
Ishibashi, M., Arai, M., Tanaka, S., Onda, K., & Hirano, T. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.35.10 · Cited by 36
Russo, I., Caroppo, F., & Alaibac, M. (2015) · Cancers · doi:10.3390/cancers7030841 · Cited by 29
“Anticancer properties of lipophilic vitamins have been investigated in sevral studies [7–15].”
Background
Metadata
- Authors
- Reichrath, J., Rech, M., Moeini, M., Meese, E., Tilgen, W., & Seifert, M.
- Venue
- Cancer Biology & Therapy
- Publisher
- Informa UK Limited
- Published
- 2007-01
- Volume
- 6
- Issue
- 1
- Pages
- 48-55
- ISSN
- 1538-4047 (ISSN-L)
- 1555-8576
- OpenAlex
- W2023997748
- Cited by
- 81
- References
- 0
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.